BJL
RNXT icon

Brighton Jones LLC’s RenovoRx RNXT Stock Holding History

Brighton Jones LLC’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,656
Closed -$13.5K – 753
2025
Q3 		$13.5K Hold
10,656
– – ﹤0.01% 1022
2025
Q2 		$14K Hold
10,656
– – ﹤0.01% 923
2025
Q1 		$10.6K Buy
+10,656
New +$12.4K ﹤0.01% 701

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
NPT
Nixon Peabody Trust Boston, Massachusetts $1.26B AUM 24.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Brighton Jones LLC's RNXT Position: Q4 2025 in Review

Brighton Jones LLC sold out of RenovoRx (RNXT) in Q4 2025, closing a stake of 10,656 shares — an estimated $13.5K sold.

Brighton Jones LLC first reported a position in RNXT in Q1 2025 and held it in 3 quarters. The position peaked at $14K in Q2 2025. 33 funds tracked by Wall St. Rank hold RNXT as of Q4 2025.

  • Brighton Jones LLC reported no remaining RenovoRx position as of Q4 2025 after selling out during the quarter.
  • Brighton Jones LLC sold 10,656 RenovoRx shares in Q4 2025, an estimated $13.5K.
  • Brighton Jones LLC first reported a position in RenovoRx in Q1 2025 and held it in 3 quarters.
  • Brighton Jones LLC's RenovoRx position peaked at $14K in Q2 2025.
  • 33 funds tracked by Wall St. Rank held RenovoRx as of Q4 2025.

Based on Brighton Jones LLC's 13F filing for Q4 2025, filed 27 Jan 2026.